Teladoc Health (NYSE:TDOC) Shares Up 4.9% - Time to Buy?

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report)'s share price rose 4.9% during trading on Thursday . The stock traded as high as $7.17 and last traded at $7.32. Approximately 382,366 shares traded hands during trading, a decline of 94% from the average daily volume of 6,218,646 shares. The stock had previously closed at $6.97.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on TDOC shares. Canaccord Genuity Group decreased their price objective on Teladoc Health from $14.00 to $12.00 and set a "buy" rating for the company in a report on Thursday, May 1st. Piper Sandler dropped their price target on shares of Teladoc Health from $13.00 to $12.00 and set an "overweight" rating for the company in a research report on Thursday, February 27th. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a research note on Thursday, May 1st. Truist Financial reduced their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a "hold" rating on the stock in a research note on Tuesday. Finally, Stifel Nicolaus dropped their target price on shares of Teladoc Health from $9.00 to $8.00 and set a "hold" rating on the stock in a report on Thursday, May 1st. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $9.60.

Teladoc Health Trading Down 0.9%

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -1.20 and a beta of 1.82. The company's 50-day moving average is $7.26 and its 200-day moving average is $9.20.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analysts' expectations of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. Research analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm's stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now directly owns 64,308 shares of the company's stock, valued at $541,473.36. This trade represents a 14.62% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.58% of the company's stock.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of TDOC. Point72 Asset Management L.P. raised its holdings in Teladoc Health by 33.6% in the fourth quarter. Point72 Asset Management L.P. now owns 11,179,863 shares of the health services provider's stock valued at $101,625,000 after buying an additional 2,813,568 shares during the period. Maple Rock Capital Partners Inc. raised its holdings in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the period. Two Sigma Investments LP purchased a new position in Teladoc Health in the fourth quarter valued at approximately $18,348,000. Two Sigma Advisers LP raised its holdings in Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider's stock valued at $20,532,000 after buying an additional 1,537,094 shares during the period. Finally, Nuveen LLC purchased a new position in Teladoc Health in the first quarter valued at approximately $11,789,000. Hedge funds and other institutional investors own 76.82% of the company's stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.